Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
Senate, Congress."
S. Hrg. 118-473 - WHY IS NOVO NORDISK CHARGING AMERICANS WITH DIABETES AND OBESITY OUTRAGEOUSLY HIGH PRICES FOR OZEMPIC AND WEGOVY?. Government. U.S. Government Publishing Office https://www.govinfo.gov/app/details/CHRG-118shrg57255.
APA
Senate, Congress. (2024, September 24). S. Hrg. 118-473 - WHY IS NOVO NORDISK CHARGING AMERICANS WITH DIABETES AND OBESITY OUTRAGEOUSLY HIGH PRICES FOR OZEMPIC AND WEGOVY?. [Government]. U.S. Government Publishing Office. https://www.govinfo.gov/app/details/CHRG-118shrg57255
MLA
Senate, Congress. S. Hrg. 118-473 - WHY IS NOVO NORDISK CHARGING AMERICANS WITH DIABETES AND OBESITY OUTRAGEOUSLY HIGH PRICES FOR OZEMPIC AND WEGOVY?. U.S. Government Publishing Office, (24 Sep 2024), https://www.govinfo.gov/app/details/CHRG-118shrg57255
Bluebook
Senate, Congress, WHY IS NOVO NORDISK CHARGING AMERICANS WITH DIABETES AND OBESITY OUTRAGEOUSLY HIGH PRICES FOR OZEMPIC AND WEGOVY?, GovInfo, (September 24, 2024), https://www.govinfo.gov/app/details/CHRG-118shrg57255
